Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders
about
The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memoryThe serotonin receptor 7 and the structural plasticity of brain circuitsEffects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsPharmacological blockade of serotonin 5-HT₇ receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmissionEffects of geissoschizine methyl ether, an indole alkaloid in Uncaria hook, a constituent of yokukansan, on human recombinant serotonin 7 receptor.The serotonin 5-HT7 receptors: two decades of research.Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders.Prepuberal stimulation of 5-HT7-R by LP-211 in a rat model of hyper-activity and attention-deficit: permanent effects on attention, brain amino acids and synaptic markers in the fronto-striatal interface.Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndromeSolid-Supported Synthesis and 5-HT7 /5-HT1A Receptor Affinity of Arylpiperazinylbutyl Derivatives of 4,5-dihydro-1,2,4-triazine-6-(1H)-one.The 5-HT(7) receptor in learning and memory.Activation of 5-hyrdoxytryptamine 7 receptors within the rat nucleus tractus solitarii modulates synaptic properties.Acute 5-HT7 receptor activation increases NMDA-evoked currents and differentially alters NMDA receptor subunit phosphorylation and trafficking in hippocampal neurons.Nitrogen-Containing Constituents of Black Cohosh: Chemistry, Structure Elucidation, and Biological Activities.Serotonin and molecular neuroimaging in humans using PET.Spatial memory deficit across aging: current insights of the role of 5-HT7 receptorsLP-211, a selective 5-HT7 receptor agonist, increases novelty-preference and promotes risk-prone behavior in rats.Evaluation of 5-HT7 Receptor Trafficking on In Vivo and In Vitro Model of Lipopolysaccharide (LPS)-Induced Inflammatory Cell Injury in Rats and LPS-Treated A549 Cells.The arylpiperazine derivatives N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide and N-benzyl-4-(2-diphenyl)-1-piperazinehexanamide exert a long-lasting inhibition of human serotonin 5-HT7 receptor binding and cAMP signaling.Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons.Prefrontal cortex executive processes affected by stress in health and disease.Evidence for genetic regulation of the human parieto-occipital 10-Hz rhythmic activity.5-HT7 receptor stimulation and blockade: a therapeutic paradox about memory formation and amnesiaActivation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics.Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.Differential responses to acute administration of a new 5-HT7-R agonist as a function of adolescent pre-treatment: phMRI and immuno-histochemical study.Assessment of 5-HT(7) Receptor Agonists Selectivity Using Nociceptive and Thermoregulation Tests in Knockout versus Wild-Type Mice.Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome.RETRACTED: Serotonin 5-HT7 receptor agonist, LP-211, exacerbates Na(+), K(+)-ATPase/Mg(2+)-ATPase imbalances in spinal cord-injured male rats.Synthesis and in vitro evaluation of oxindole derivatives as potential radioligands for 5-HT(7) receptor imaging with PET.Emotional and risk seeking behavior after prepuberal subchronic or adult acute stimulation of 5-HT7-Rs in Naples High Excitability rats.Modulation of 5-HT7 receptor: effect on object recognition performances in mice.Synthesis and pharmacological evaluation of novel tricyclic[2,1-f]theophylline derivatives.Neuropsychiatric complications in a patient with Marfan syndrome.Quinolinesulfonamides of aryloxy-/arylthio-ethyl piperidines: influence of an arylether fragment on 5-HT1A/5-HT7 receptor selectivity.Effects of amisulpride on human resting cerebral perfusion.Stimulation of 5-HT7 receptor during adolescence determines its persistent upregulation in adult rat forebrain areas.Pharmacophore Comparison and Development of Recently Discovered Long Chain Arylpiperazine and Sulfonamide Based 5-HT7 Ligands.In the search for a lead structure among series of potent and selective hydantoin 5-HT7 R agents: The drug-likeness in vitro study.
P2860
Q26795511-2831BFB3-67B0-42CF-AF48-F7BEB148EBA0Q27000420-5D4A311E-DDC4-49D0-8342-B70E21E31453Q28533794-BAC5F4A2-849F-464F-9573-280B02D487F2Q30486707-B820D48A-B53E-4AB9-BBFC-6664B19C6271Q33942069-1C4E0A57-D594-4CB0-821B-26A1FD369537Q34299127-B0418269-89E5-457F-97BE-FADF4C019476Q34371660-7C698C57-2F21-4E7C-870C-A3B403948246Q34425116-FE1D94F7-AA08-477C-8C15-6FED8C7A7D44Q35141699-85D09C33-0014-4D67-8F36-C7BD3A4975F5Q35408368-DDF76BF4-27D1-4868-997A-CFC91E172317Q35561899-F9C6448F-00B1-48C1-8CFA-CAD4B1CA9EBEQ35848311-8E0CA1F7-BDA7-459B-B4EF-962A4E3FF412Q36654900-DF23B24D-0EB5-4181-9AB1-7E9DF71713BDQ36866942-4675E3C7-E873-45FC-9490-94DAA9CE296BQ37375330-98D0132F-1C02-4D03-AE72-9FAB96D9AEABQ37938794-06BFD375-0546-4733-85D8-0E7E9D1342E9Q38340479-840FE7A8-E3EF-4BA4-8849-A47368A0935DQ38650429-25E6692E-DF58-4F83-9430-59A91FDB5307Q38748614-6054267E-B912-43B3-B7DC-9971931EFC99Q38928549-7A214046-BC77-4342-B622-C46D25418D4DQ38999658-49B687E6-5A49-4DE1-B098-374506EF1BA5Q39424256-6757ADAC-FD24-4C98-8034-196B0A1C3583Q39681142-1749AA22-E31A-4F85-B170-BFE8C99F6817Q40584830-F1BA3B3E-60CE-434E-9F3D-306F3776C7F9Q41150716-F64163A1-5D5D-4C3E-AB41-2F6E2EA8EE2AQ41433244-30A8A736-C170-4896-BAF6-E37B44FA72A0Q41613761-FE707864-DFF3-4A6F-A427-E185E8F7B763Q41866617-3F7ACAE8-C8B8-4CA2-B1B6-C848D72B60F1Q42057101-1530754D-B3D3-4FCA-8416-2E4B5D7C88ADQ42129572-9DC4E49E-DA9E-4B18-B29E-4D9357B82C01Q42422583-1AFDA34A-DE59-4AEF-B547-99948B05F595Q42629945-9AFD6F49-2B41-4E9D-80EF-4F25A33C9827Q43540772-EE29AD96-6D25-42DF-9D9B-2755F4D97E98Q45342153-7B3F09FB-232B-494F-9B87-3A94A1C9C1A4Q45797050-05F8DB0C-1F01-46B6-B259-AF8341A477C9Q46611878-D3225167-7D43-4CA0-AD1A-91F692C0F1E6Q46667464-62ED9E04-79BD-41B0-BA5E-855673A8B1F0Q47615306-555F5531-08B8-4650-B2CF-20767EAE60EFQ47770513-C618B88E-AF78-4CFA-B8D6-D3E128008958Q47833839-6C98B94F-E479-4504-A50C-EAFB8790AB40
P2860
Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Serotonin 5-HT7 receptor agent ...... ntral nervous system disorders
@ast
Serotonin 5-HT7 receptor agent ...... ntral nervous system disorders
@en
Serotonin 5-HT7 receptor agent ...... ntral nervous system disorders
@nl
type
label
Serotonin 5-HT7 receptor agent ...... ntral nervous system disorders
@ast
Serotonin 5-HT7 receptor agent ...... ntral nervous system disorders
@en
Serotonin 5-HT7 receptor agent ...... ntral nervous system disorders
@nl
prefLabel
Serotonin 5-HT7 receptor agent ...... ntral nervous system disorders
@ast
Serotonin 5-HT7 receptor agent ...... ntral nervous system disorders
@en
Serotonin 5-HT7 receptor agent ...... ntral nervous system disorders
@nl
P2093
P2860
P3181
P1476
Serotonin 5-HT7 receptor agent ...... ntral nervous system disorders
@en
P2093
Francesco Berardi
Peter B Hedlund
Roberto Perrone
P2860
P304
P3181
P356
10.1016/J.PHARMTHERA.2010.08.013
P407
P577
2010-10-20T00:00:00Z